Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Taurine Supplementation as a Novel Therapeutic Approach for Neurocognitive Symptoms in Long COVID

NCT06721949 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT06721949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06721949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Taurine Supplementation as a Novel Therapeutic Approach for Neurocognitive Symptoms in Long COVID
Lead sponsor
University of Alberta
Phase
Phase 2/3
Overall status
Recruiting
Start date
November 18, 2025
Completion date
December 31, 2028
Enrollment
300 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

long covid